MedTrace Logo

Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania

NCT05256862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2974

Last updated 2025-03-20

No results posted yet for this study

Summary

This study is to analyse the effect of a bundle of measures on the proportion of females being screened for cervical cancer in the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO), comparing the time period before implementation (01/2017-01/2020) and after implementation (02/2020-06/2022). It is to assess the performance of two novel diagnostic tests (QuantiGene-molecular profiling histology (QG-MPH) and PT Monitor® immunoassay) and established tests (Seegene Anyplex™ II 28 HPV Test and Prevo-check®) as potential triage tests for the development of future clinical decision algorithms for CC screening.

Conditions

  • Cervical Cancer Screening

Interventions

OTHER

Data collection

Data collection * on the effect of a bundle of measures on the proportion of females being screened for cervical cancer in the Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) comparing the time period before implementation (01/2017-01/2020) and after implementation (02/2020-06/2022) * on the performance of three novel tests as triage tool in the screening algorithm, QG-MPH, Prevo-check® and PT Monitor®

Sponsors & Collaborators

  • Krebsforschung Schweiz, Bern, Switzerland

    collaborator OTHER

  • Abviris Deutschland GmbH

    collaborator UNKNOWN

  • Charité-University Medicine (Berlin, Germany)

    collaborator UNKNOWN

  • Swiss Tropical and Public Health Institute (Switzerland)

    collaborator UNKNOWN

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Ivana Di Salvo, MD · University Women's Hospital Basel

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-27
Primary Completion
2024-10-18
Completion
2024-10-18

Countries

  • Tanzania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05256862 on ClinicalTrials.gov